loading
전일 마감가:
$5.91
열려 있는:
$5.13
하루 거래량:
410.58K
Relative Volume:
1.49
시가총액:
$11.76M
수익:
-
순이익/손실:
$-16.31M
주가수익비율:
-10.59
EPS:
-0.54
순현금흐름:
$-7.46M
1주 성능:
+56.97%
1개월 성능:
+20.01%
6개월 성능:
+3.55%
1년 성능:
-62.86%
1일 변동 폭
Value
$4.80
$5.96
1주일 범위
Value
$2.31
$6.69
52주 변동 폭
Value
$2.31
$15.40

Coeptis Therapeutics Holdings Inc Stock (COEP) Company Profile

Name
명칭
Coeptis Therapeutics Holdings Inc
Name
전화
724-934-6467
Name
주소
105 BRADFORD ROAD, SUITE 420, WEXFORD
Name
직원
7
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
COEP's Discussions on Twitter

COEP을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
 icon
COEP
COEPTIS THERAPEUTICS INC
0.415 2.70M 0 0 0 0.00
 icon
PSNYW
Polestar Automotive Holding Uk
0.29 612.00M 2.07B -1.42B -1.37B -0.6765
 icon
GOODO
Gladstone Commercial Corporation
20.65 372.90M 0 0 0 0.00
 icon
MOBBW
Mobilicom Limited Warrants
0.82 278.60M 0 0 0 0.00
 icon
SHMD
Schmid Group N V
3.01 129.62M 0 0 0 0.00
 icon
JUNE
Dhandho Junoon Etf
3.65 47.48M 0 0 0 0.00

Coeptis Therapeutics Holdings Inc 주식(COEP)의 최신 뉴스

pulisher
07:35 AM

Coeptis Therapeutics Holdings Inc (NASDAQ: COEP): Getting A Free Pass? - Stocks Register

07:35 AM
pulisher
Jan 03, 2025

Stock market today: Heartcore Enterprises -20.07%, Caravelle International -16.63% among biggest losers in early trading - Business Upturn

Jan 03, 2025
pulisher
Jan 02, 2025

Coeptis Therapeutics (COEP) Stock Gains Pre-Hour Traction - Stocks Telegraph

Jan 02, 2025
pulisher
Jan 01, 2025

Coeptis Therapeutics Announces Phase 1 Data on DVX201 for COVID-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical Development - Marketscreener.com

Jan 01, 2025
pulisher
Dec 31, 2024

Coeptis Therapeutics Holdings, Inc. Adds Autoimmune Indications to Exclusive License Agreement with University of Pittsburgh for SNAP-CAR T and SNAP-CAR NK - Marketscreener.com

Dec 31, 2024
pulisher
Dec 31, 2024

Coeptis Therapeutics Holdings, Inc. signed a binding Letter of Intent to acquire NexGenAI Affiliates Network from NexGenAI Solutions Group, Inc. - Marketscreener.com

Dec 31, 2024
pulisher
Dec 31, 2024

PHLX Swiss Franc (XDS) QuotePress Release - The Globe and Mail

Dec 31, 2024
pulisher
Dec 31, 2024

S&P 500 Growth (IGX) QuotePress Release - The Globe and Mail

Dec 31, 2024
pulisher
Dec 31, 2024

Nasdaq Biotechnology Index (NBI) QuotePress Release - The Globe and Mail

Dec 31, 2024
pulisher
Dec 31, 2024

S&P 500 Health Care [Sector] (SRHC) QuotePress Release - The Globe and Mail

Dec 31, 2024
pulisher
Dec 31, 2024

S&P 500 Consumer Discretionary [Sector] (SRCD) QuotePress Release - The Globe and Mail

Dec 31, 2024
pulisher
Dec 31, 2024

KBW Property & Casualty Index (KPX) QuotePress Release - The Globe and Mail

Dec 31, 2024
pulisher
Dec 31, 2024

Trading Halt Occurred During This Micro Cap's EOY Surge - MSN

Dec 31, 2024
pulisher
Dec 31, 2024

Midday Market Movers: Biggest Stock Declines of the Day – Stock Market - HPBL

Dec 31, 2024
pulisher
Dec 31, 2024

Stock market news: Coeptis Therapeutics Holdings -96.03%, OptiNose -93.07% among biggest losers during mid day trading - Business Upturn

Dec 31, 2024
pulisher
Dec 31, 2024

Stock market news: Coeptis Therapeutics Holdings declined by 96.03% whereas Baird Medical Investment Holdings +496.89% during mid day trading - Business Upturn

Dec 31, 2024
pulisher
Dec 31, 2024

Stock market today: Coeptis Therapeutics Holdings -95.79%, OptiNose -93.64% among biggest losers in early trading - Business Upturn

Dec 31, 2024
pulisher
Dec 31, 2024

Stock market today: Coeptis Therapeutics Holdings plunged by 95.98% whereas Baird Medical Investment Holdings gained over 201.90% in early trading - Business Upturn

Dec 31, 2024
pulisher
Dec 28, 2024

Coeptis Therapeutics announces reverse stock split - MSN

Dec 28, 2024
pulisher
Dec 27, 2024

Coeptis Therapeutics announces reverse stock split plan to remain on the Nasdaq - The Business Journals

Dec 27, 2024
pulisher
Dec 27, 2024

Why Is Coeptis Therapeutics Stock Falling On Friday? - Yahoo Finance

Dec 27, 2024
pulisher
Dec 27, 2024

Coeptis Therapeutics Announced an Acquisition and a New Divison Launch - Martechcube

Dec 27, 2024
pulisher
Dec 27, 2024

Coeptis Therapeutics Announces Reverse Stock Split - Lelezard

Dec 27, 2024
pulisher
Dec 27, 2024

Coeptis Therapeutics announces 1-for-20 reverse stock split - Investing.com

Dec 27, 2024
pulisher
Dec 27, 2024

Coeptis Therapeutics (COEP) Announces 1-for-20 Reverse Stock Split to Maintain Nasdaq Listing - StockTitan

Dec 27, 2024
pulisher
Dec 27, 2024

Coeptis expands with AI platform acquisition and new tech division By Investing.com - Investing.com Canada

Dec 27, 2024
pulisher
Dec 27, 2024

Coeptis Therapeutics Announces Reverse Stock Split (PR Newswire) - Aktiellt

Dec 27, 2024
pulisher
Dec 26, 2024

Coeptis Therapeutics completes acquisition of AI company, launching technology division - The Business Journals

Dec 26, 2024
pulisher
Dec 26, 2024

Coeptis Therapeutics Holdings, Inc. completed the acquisition of NexGenAI Affiliates Network from NexGenAI Solutions Group, Inc. - Marketscreener.com

Dec 26, 2024
pulisher
Dec 26, 2024

Stock market today: Millennium Group International surged by 318.96% while SciSparc increased by 153.01% in early trading - Business Upturn

Dec 26, 2024
pulisher
Dec 26, 2024

Coeptis Therapeutics Makes Bold Strides in Innovation with the Acquisition of NexGenAI Affiliates Network Platform and Launch of Coeptis Technologies - IT News Online

Dec 26, 2024
pulisher
Dec 26, 2024

Coeptis expands with AI platform acquisition and new tech division - Investing.com

Dec 26, 2024
pulisher
Dec 26, 2024

Coeptis (NASDAQ: COEP) Launches AI Division, Acquires NexGenAI Platform for Biotech Marketing Automation - StockTitan

Dec 26, 2024
pulisher
Dec 21, 2024

Coeptis Therapeutics Holdings, Inc. Reports Voting Results from Annual Meeting - Defense World

Dec 21, 2024
pulisher
Dec 20, 2024

COEP Stock Plummets to 52-Week Low at $0.15 Amid Market Challenges - Investing.com Canada

Dec 20, 2024
pulisher
Dec 17, 2024

Short Interest in Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) Increases By 11.0% - Defense World

Dec 17, 2024
pulisher
Dec 14, 2024

Financial Comparison: Coeptis Therapeutics (NASDAQ:COEP) & PharmaCyte Biotech (NASDAQ:PMCB) - Defense World

Dec 14, 2024
pulisher
Dec 12, 2024

Coeptis launching technology division with AI and data security-focused acquisitions - The Business Journals

Dec 12, 2024
pulisher
Dec 12, 2024

Coeptis Launches New Technology Division - Contract Pharma

Dec 12, 2024
pulisher
Dec 12, 2024

Coeptis Therapeutics Unveils New Technology Division: Coeptis Te - GuruFocus.com

Dec 12, 2024
pulisher
Dec 12, 2024

Coeptis Therapeutics launches tech division, eyes data security - Investing.com

Dec 12, 2024
pulisher
Dec 12, 2024

Coeptis Therapeutics Unveils New Technology Division: Coeptis Technologies - Marketscreener.com

Dec 12, 2024
pulisher
Dec 12, 2024

Why DBV Technologies Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket - Benzinga

Dec 12, 2024
pulisher
Dec 11, 2024

Coeptis Therapeutics Expands License Agreement with Deverra to Include Pandemic Preparedness, and Emergency Use - The Eastern Progress Online

Dec 11, 2024
pulisher
Dec 04, 2024

Coeptis Therapeutics to Acquire NexGenAI for Enhanced AI Tools By Investing.com - Investing.com South Africa

Dec 04, 2024
pulisher
Dec 04, 2024

Coeptis Therapeutics Holdings to Acquire NexGenAI Affiliates Network, - citybiz

Dec 04, 2024
pulisher
Dec 03, 2024

Coeptis Therapeutics to Acquire NexGenAI for Enhanced AI Tools - Investing.com India

Dec 03, 2024
pulisher
Dec 03, 2024

Coeptis Acquires AI-Powered Marketing Platform - Contract Pharma

Dec 03, 2024
pulisher
Dec 03, 2024

Coeptis Therapeutics takes steps to acquire NexGenAI Affiliates Network - The Business Journals

Dec 03, 2024
pulisher
Dec 03, 2024

Coeptis Therapeutics Executes Binding Letter of Intent to Acquire Ai-powered Marketing Solutions for Biotech, Pharmaceutical and Other Industries - PR Newswire

Dec 03, 2024
pulisher
Dec 02, 2024

Could BigBear.ai Become the Next Palantir Technologies? - AOL

Dec 02, 2024

Coeptis Therapeutics Holdings Inc (COEP) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Coeptis Therapeutics Holdings Inc 주식 (COEP) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
DeSilva Tara
Director
Jan 12 '24
Buy
0.58
2,266
1,305
32,266
Yerace Daniel Alexander
VP of Operations
Jan 05 '24
Buy
0.69
10,850
7,486
1,071,455
Salkind Gene
Director
Jan 05 '24
Buy
0.69
11,600
8,004
284,056
Mehalick David
CEO and President
Jan 08 '24
Buy
0.66
20,004
13,263
2,782,615
Mehalick David
CEO and President
Jan 05 '24
Buy
0.69
5,050
3,484
2,762,611
Cochran Christopher P.
Director
Jan 05 '24
Buy
0.77
7,000
5,390
37,000
$18.24
price down icon 0.60%
$21.47
price up icon 2.24%
$356.33
price down icon 1.08%
$42.18
price up icon 0.43%
$184.71
price up icon 0.49%
$115.79
price up icon 0.42%
자본화:     |  볼륨(24시간):